Human Complement C6 Antibody Conjugated to Biotin

<strong>Human Complement C6 Antibody Conjugated to Biotin</strong>_x000D_ <strong>Catalog number:</strong> B2014721_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Human Complement Monoclonal Antibody (Biotin Conjugate)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Falk RJ, Dalmasso AP, Kim Y, Tsai CH, Scheinman JI, Gewurz H, Michael AF. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease J Clin Invest. 1983 Aug;72(2):560-73._x000D_ 2: Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex Scand J Immunol. 1985 Aug;22(2):197-202._x000D_ 3: Zilberman-Itskovich S, Abu-Hamad R, Stark M, Efrati S. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury Ren Fail. 2019 Nov;41(1):967-975._x000D_ 4: Mollnes TE, Lea T, Harboe M, Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma Scand J Immunol. 1985 Aug;22(2):183-95._x000D_ 5: Würzner R, Orren A, Potter P, Morgan BP, Ponard D, Späth P, Brai M, Schulze M, Happe L, Götze O. Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals Clin Exp Immunol. 1991 Mar;83(3):430-7._x000D_ 6: Biesecker G, Wagner JL, Hugli TE. The release of C5a in complement-activated serum does not require C6 J Immunol. 1989 Aug 15;143(4):1228-32._x000D_ 7: Lopes dos Santos M, Yeda FP, Tsuruta LR, Horta BB, Pimenta AA Jr, Degaki TL, Soares IC, Tuma MC, Okamoto OK, Alves VA, Old LJ, Ritter G, Moro AM. Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer PLoS One. 2013 Jul 31;8(7):e70332._x000D_ 8: Sorkin LS, Otto M, Baldwin WM 3rd, Vail E, Gillies SD, Handgretinger R, Barfield RC, Yu HM, Yu AL. Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia Pain. 2010 Apr;149(1):135-142._x000D_ 9: Rother RP, Squinto SP, Mason JM, Rollins SA. Protection of retroviral vector particles in human blood through complement inhibition Hum Gene Ther. 1995 Apr;6(4):429-35._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/9146972">10: Johnson RJ. Involvement of complement components in renal disease Curr Opin Nephrol Hypertens. 1997 Mar;6(2):120-7. </a>_x000D_ _x000D_ <strong>Products Related to Human Complement C6 Antibody Conjugated to Biotin can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>